Recent lessons learned for ex-vivo platelet production

Area of Science:

• Hematology
• Biotechnology
• Regenerative Medicine

Background:

• Platelet transfusions are vital but face challenges like infection risk, alloimmunization, limited donor supply, and short shelf life.
• Generating sufficient platelets in vitro remains a significant hurdle for clinical application.

Purpose of the Study:

• To review recent advances in regulating megakaryocyte maturation, expansion, and platelet formation.
• To discuss alternative therapies for inducing platelet production.

Main Methods:

• Investigated bone marrow niche cells and explant-based bioreactors for enhanced ex vivo platelet production.
• Examined chemical inhibitors to promote megakaryocyte maturation and expansion.
• Studied microparticles and novel membrane budding for platelet formation.
• Identified a chemical inhibitor to improve cold-stored platelets.

Main Results:

• Ex vivo bioreactors and specific niche cells show promise for boosting platelet production.
• Chemical inhibitors and microparticles effectively enhance megakaryocyte maturation and platelet formation.
• Novel mechanisms of platelet formation, like membrane budding, have been identified.
• Improvements in cold storage of platelets have been achieved.

Conclusions:

• Recent breakthroughs in megakaryocyte regulation and platelet production offer potential for in vitro platelet generation.
• These advances bring the field closer to producing platelets without relying on human donors.